Literature DB >> 19169235

Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to traumatic choroidal rupture.

B Chanana, R V Azad, N Kumar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19169235     DOI： 10.1038/eye.2008.434

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  3 in total

1.  Intravitreal ranibizumab for choroidal neovascularization related to traumatic Bruch's membrane rupture.

Authors:  Feng Liang; Nathalie Puche; Gisèle Soubrane; Eric H Souied
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-26       Impact factor: 3.117

2.  Optical Coherence Tomography Angiography Evolution of Choroidal Neovascular Membrane in Choroidal Rupture Managed by Intravitreal Bevacizumab.

Authors:  Massimo Lorusso; Luisa Micelli Ferrari; Eleni Nikolopoulou; Tommaso Micelli Ferrari
Journal:  Case Rep Ophthalmol Med       Date:  2019-01-06

Review 3.  Traumatic submacular hemorrhage: available treatment options and synthesis of the literature.

Authors:  Giamberto Casini; Pasquale Loiudice; Martina Menchini; Francesco Sartini; Stefano De Cillà; Michele Figus; Marco Nardi
Journal:  Int J Retina Vitreous       Date:  2019-12-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.